Shire dispels doubts about New River acquisition
March 12, 2007Sales and Marketing
Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …
Making your mark in 100 days
March 12, 2007Business Services management, recruitment
Congratulatons, you've got the job – you're a senior executive – maybe even the chief executive officer. It's the opportunity …
NICE judges Tarceva too expensive for NHS
March 9, 2007Sales and Marketing Tarceva, lung cancer
Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …
Huntsworth makes US acquisition
March 9, 2007Medical Communications
Communications group Huntsworth Health has acquired US agency Dorland Global Corporation, extending its reach into the world's largest pharmaceutical market.Dorland …
Doctors reassured by hospital reconfiguration report
March 9, 2007The BMA has said it is "reassured" by Sir Ian Carruthers' report on hospital reconfiguration – the controversial measure which …
Trading Places
March 9, 2007Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment
Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …
PM hints pharma could avoid ‘value-based’ pricing
March 9, 2007Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing
Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
GSK to test Tycerb for head and neck cancer
March 7, 2007Sales and Marketing breast cancer
GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …
Merck lung cancer vaccine enters phase III trials
March 7, 2007Research and Development
A therapeutic vaccine for the most common form of lung cancer has enrolled its first patient into global phase III …
Academy launched to fill NHS training need
March 7, 2007NHS
Training and development company Excel Communications has launched a new initiative to allow pharma companies to sponsor courses for doctors.The …
Eisai prepares for Inovelon UK launch
March 7, 2007Sales and Marketing
Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …
Work begins on Eisai’s Knowledge Centre
March 7, 2007Research and Development, Sales and Marketing
Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …
Pfizer’s controversial new UK supply chain goes live
March 5, 2007Manufacturing and Production
Pfizer has launched its new single wholesaler supply chain in the UK, after a last-minute legal challenge was defeated.The pharmaceutical …
PR: messages from the frontline
March 5, 2007Medical Communications, Sales and Marketing public relations, strategy
Media rationalisation & technology"Here is the news but not as we know it! The media landscape is constantly evolving as …
Prime Minister opens Amgen European R&D centre
March 2, 2007Research and Development
Prime Minister Tony Blair has opened Amgen's new European Development Centre in Uxbridge, London.The centre is the Californian biotech company's …
Sales data specialists Cegedim to buy rivals Dendrite
March 2, 2007Sales and Marketing Cegedim
French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …
New clinical trials network to boost patient recruitment in UK
March 2, 2007Research and Development
Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …
Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK
March 2, 2007Sales and Marketing
Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …
Court orders withdrawal of generic Lipitor in Denmark
March 2, 2007Sales and Marketing
Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …
Two products fuelling Actelion’s growth spurt
March 2, 2007Sales and Marketing
Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
